pieter_maas
I have made most of the reconstitution mistakes so you do not have to.
14kreputation
30answers
4accepted
22questions
0·1·7badges g·s·b
58tags
97Does hair thinning at week eight of survodutide usually resolve without a dose change?accepted · answered 24 Sept 2025 · hair-loss, titration, survodutide69Does aspartimide formation of oral semaglutide at room temperature show up as a loss of content or of purity?answered 22 Dec 2024 · peptide-stability, content-assay, purity56What did the placebo arm of SURMOUNT-OSA report for hair thinning?accepted · answered 11 Mar 2026 · clinical-trials, hair-loss56What is the thermal exposure on a Xi’an to Poland lane in summer?answered 22 Dec 2025 · cold-chain, international-shipping, storage47What did the placebo arm of SURMOUNT-5 report for injection-site erythema?answered 17 Aug 2024 · clinical-trials, injection-site-reaction47What is the reported incidence of hair thinning on oral semaglutide in PIONEER-1?answered 15 Sept 2024 · hair-loss, clinical-trials, oral-glp140Does cystatin C tell me anything about hepatic fat on survodutide?answered 8 Apr 2025 · liver-enzymes, mash, bloodwork39Is hair thinning on oral semaglutide dose-dependent or dose-rate dependent?accepted · answered 20 Jun 2026 · hair-loss, titration, oral-glp138Does hydrolysis dominate for orforglipron held at 25 °C?answered 13 Feb 2025 · peptide-stability, storage, hplc36Does vomiting at week nine of cagrilintide usually resolve without a dose change?answered 9 Jun 2026 · vomiting, titration, amylin36What does REDEFINE-1 tell me about injection-site erythema at the 2.4 mg dose?accepted · answered 19 Jun 2025 · clinical-trials, injection-site-reaction, titration35Is a rising lipase without symptoms actionable?answered 24 Feb 2026 · pancreatitis, bloodwork, harm-reduction35What did the placebo arm of STEP 1 report for hair thinning?answered 20 Oct 2024 · clinical-trials, hair-loss34What is the reported incidence of injection-site erythema on retatrutide in TRIUMPH-1?answered 7 Apr 2025 · injection-site-reaction, clinical-trials, retatrutide32Would you re-test oral semaglutide after three weeks at 40 °C, or accept the original certificate?answered 25 Oct 2025 · batch-testing, peptide-stability, coa31Does holding at 5 mg for six weeks before escalating reduce injection-site erythema?answered 7 Sept 2025 · titration, injection-site-reaction, dose-escalation27At what point does upper abdominal pain warrant urgent assessment?answered 3 Dec 2024 · pancreatitis, gi-side-effects, harm-reduction25Does site rotation actually have evidence behind it, and what kind of reaction warrants stopping?answered 14 Jul 2026 · injection-site-reaction, injection-technique, subcutaneous23What differentiates an injection-site nodule from an infection?answered 1 Jul 2025 · injection-site-reaction, subcutaneous, harm-reduction21Does holding at 0.5 mg for three weeks before escalating reduce injection-site erythema?answered 15 Feb 2026 · titration, injection-site-reaction, dose-escalation21What did the placebo arm of SURMOUNT-OSA report for injection-site erythema?answered 30 Jun 2024 · clinical-trials, injection-site-reaction18What did the placebo arm of ATTAIN-1 report for hair thinning?answered 13 Jan 2025 · clinical-trials, hair-loss18Why does racemisation accelerate at 40 °C rather than proceeding linearly?answered 4 Mar 2025 · peptide-stability, storage, hplc15What did the placebo arm of SURPASS-3 report for hair thinning?answered 28 Apr 2025 · clinical-trials, hair-loss14Does hair thinning at week six of dulaglutide usually resolve without a dose change?answered 29 Aug 2025 · hair-loss, titration, dulaglutide14Does holding at 5 mg for six weeks before escalating reduce injection-site erythema?answered 2 Nov 2025 · titration, injection-site-reaction, dose-escalation14What did the placebo arm of PIONEER-1 report for injection-site erythema?answered 28 Feb 2025 · clinical-trials, injection-site-reaction9Is lipase worth drawing at baseline before starting cagrilintide?answered 30 May 2026 · bloodwork, harm-reduction, a1c6What is the dead-space loss per draw with a 31G needle at 4 mg/mL?answered 11 Feb 2026 · dead-space, insulin-syringe, dosing-math3Is injection-site erythema on survodutide dose-dependent or dose-rate dependent?answered 4 Sept 2024 · injection-site-reaction, titration, survodutide